Chondrosarcoma-associated gene 2/3 protein (34-48)

Chondrosarcoma-associated gene 2/3 protein (34-48) is a synthetic peptide fragment corresponding to residues 34 through 48 of the chondrosarcoma-associated gene 2/3 protein. As a well-defined peptide segment, it serves as a valuable tool for elucidating the structure-function relationships of the parent protein, which has been implicated in the molecular pathology of chondrosarcoma and related connective tissue disorders. The defined sequence allows for precise interrogation of protein interactions, post-translational modifications, and immunological responses, making it a versatile reagent in advanced biochemical and molecular biology research.

Peptide mapping: Researchers frequently utilize this peptide fragment in peptide mapping studies to identify and characterize antigenic epitopes within the chondrosarcoma-associated gene 2/3 protein. The defined sequence enables the detailed analysis of protein domains responsible for antibody recognition, facilitating the development of specific immunoassays and supporting investigations into immune surveillance mechanisms in tumorigenesis. By serving as a reference peptide, it aids in the validation of antibody specificity and the refinement of peptide-based detection platforms.

Protein-protein interaction analysis: The 34-48 segment is an effective probe for dissecting protein-protein interactions that involve the chondrosarcoma-associated gene 2/3 protein. In vitro binding assays, such as pull-down experiments or surface plasmon resonance, can employ this peptide to map binding sites and assess the affinity of partner molecules. Insights gained from these studies contribute to understanding the molecular networks that regulate cell signaling, adhesion, and extracellular matrix remodeling in chondrosarcoma and related pathologies.

Post-translational modification studies: The defined amino acid sequence of this peptide makes it suitable for investigating specific post-translational modifications, such as phosphorylation, methylation, or acetylation, that may occur within this region of the full-length protein. Researchers can use synthetic versions of the peptide, with or without targeted modifications, to evaluate the functional implications of these alterations on protein activity, stability, and cellular localization. Such studies are essential for elucidating regulatory mechanisms and identifying potential biochemical markers of disease progression.

Peptide-based assay development: The chondrosarcoma-associated gene 2/3 protein (34-48) peptide is a valuable component in the design and optimization of peptide-based assays, including enzyme-linked immunosorbent assays (ELISA), competitive binding assays, and mass spectrometry-based quantification methods. Its well-characterized sequence and consistent performance enable the generation of robust calibration standards and positive controls, ensuring reproducibility and accuracy in quantitative and qualitative analyses of biological samples.

Structural and conformational analysis: The isolated peptide fragment provides a model system for exploring the local secondary structure and conformational dynamics of the corresponding region within the parent protein. Techniques such as circular dichroism spectroscopy, nuclear magnetic resonance (NMR), or X-ray crystallography can be applied to study the folding properties, stability, and interaction surfaces of this segment. These insights are instrumental in advancing the understanding of protein architecture and the structural determinants of biological function in the context of chondrosarcoma-associated proteins.

1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists

2. Emu oil in combination with other active ingredients for treating skin imperfections

3. TMEM16F and dynamins control expansive plasma membrane reservoirs

4. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum